|
|
||||||||
Articles |
Ivalon particles were used for 80 hepatic artery embolizations in 50 patients who had either primary or metastatic hepatic neoplasms. Ten patients died within 1-5 months and the remaining 40 patients were still alive. The post-hepatic embolization syndrome was identical to that following Gelfoam embolization. Follow-up hepatic angiography in 20 patients revealed tumor response to embolization in 17 patients. Ivalon particles were easier to use and caused more peripheral and persistent occlusion than Gelfoam. The results suggest that Ivalon particles were safe and feasible for hepatic artery embolization.
This article has been cited by other articles:
![]() |
L. M. Bavisotto, N. H. Patel, S. J. Althaus, D. M. Coldwell, H. V. Nghiem, T. Thompson, B. Storer, and C. R. Thomas Jr. Hepatic Transcatheter Arterial Chemoembolization Alternating with Systemic Protracted Continuous Infusion 5-Fluorouracil for Gastrointestinal Malignancies Metastatic to Liver: A Phase II Trial of the Puget Sound Oncology Consortium (PSOC 1104) Clin. Cancer Res., January 1, 1999; 5(1): 95 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Jeng and H.-J. Chiang Delayed Formation of Gallstones After Transcatheter Arterial Embolization for Hepatocellular Carcinoma: Is Elective Cholecystectomy Advisable During Hepatectomy? Arch Surg, November 1, 1989; 124(11): 1319 - 1322. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |